Search Orphan Drug Designations and Approvals
-
Generic Name: | methimazole and liothyronine sodium |
---|---|
Date Designated: | 06/02/2016 |
Orphan Designation: | Treatment of glioblastoma multiforme. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Musli Thyropeutics Ltd 6 HaGefen Street zur Moshe, Center District Israel The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-